Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


01.05.2017

1 Acta Ophthalmol
3 Am J Cardiol
1 Am J Med
1 Biochem Biophys Res Commun
1 BMC Ophthalmol
1 Br J Ophthalmol
1 Diabetes
2 Diabetes Care
2 Diabetes Educ
10 Diabetes Obes Metab
6 Diabetologia
1 Eur J Endocrinol
3 J Diabetes Complications
1 J Hypertens
3 JAMA
4 Lancet Diabetes Endocrinol
1 Med Care
1 N Engl J Med
2 Pediatr Diabetes
1 PLoS Comput Biol
7 PLoS One
1 Transplant Proc


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Ophthalmol

  1. LARSEN MB, Henriksen JE, Grauslund J, Peto T, et al
    Prevalence and risk factors for diabetic retinopathy in 17 152 patients from the island of Funen, Denmark.
    Acta Ophthalmol. 2017 Apr 26. doi: 10.1111/aos.13449.
    PubMed     Text format     Abstract available


    Am J Cardiol

  2. KOSMIDOU I, Redfors B, Dordi R, Dizon JM, et al
    Incidence, Predictors, and Outcomes of High-Grade Atrioventricular Block in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (from the HORIZONS-AMI Trial).
    Am J Cardiol. 2017 Feb 16. pii: S0002-9149(17)30118.
    PubMed     Text format     Abstract available

  3. ANDO T, Akintoye E, Telila T, Briasoulis A, et al
    Trends in Vascular Complications in High-Risk Patients Following Transcatheter Aortic Valve Replacement in the United States.
    Am J Cardiol. 2017 Feb 10. pii: S0002-9149(17)30127.
    PubMed     Text format     Abstract available

  4. KARGOLI F, Shulman E, Aagaard P, Briceno DF, et al
    Socioeconomic Status as a Predictor of Mortality in Patients Admitted With Atrial Fibrillation.
    Am J Cardiol. 2017;119:1378-1381.
    PubMed     Text format     Abstract available


    Am J Med

  5. EDELMAN SV, Hollander PA, Wright EE Jr
    Where Are We Now? A Clinicians' Guide to the Use of Follow-On Insulin for Patients with Diabetes.
    Am J Med. 2017;130:614.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  6. XIONG C, Lu J, Wang X, Masucci MV, et al
    Salvianolate attenuates renal fibrosis in rat models of diabetic nephropathy by inhibiting inflammation and oxidative stress mechanisms.
    Biochem Biophys Res Commun. 2017 Apr 20. pii: S0006-291X(17)30776.
    PubMed     Text format     Abstract available


    BMC Ophthalmol

  7. YOKOTA S, Takihara Y, Takamura Y, Inatani M, et al
    Circumpapillary retinal nerve fiber layer thickness, anterior lamina cribrosa depth, and lamina cribrosa thickness in neovascular glaucoma secondary to proliferative diabetic retinopathy: a cross-sectional study.
    BMC Ophthalmol. 2017;17:57.
    PubMed     Text format     Abstract available


    Br J Ophthalmol

  8. CICINELLI MV, Cavalleri M, Querques L, Rabiolo A, et al
    Early response to ranibizumab predictive of functional outcome after dexamethasone for unresponsive diabetic macular oedema.
    Br J Ophthalmol. 2017 Apr 21. pii: bjophthalmol-2017-310242.
    PubMed     Text format     Abstract available


    Diabetes

  9. VAEGGEMOSE M, Pham M, Ringgaard S, Tankisi H, et al
    Magnetic Resonance Neurography Visualizes Abnormalities in Sciatic and Tibial Nerves in Patients with Type 1 Diabetes and Neuropathy.
    Diabetes. 2017 Apr 21. pii: db161049. doi: 10.2337/db16-1049.
    PubMed     Text format     Abstract available


    Diabetes Care

  10. SOLOMON SD, Chew E, Duh EJ, Sobrin L, et al
    Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412-418.
    Diabetes Care. 2017 Apr 21. pii: dc17er06e. doi: 10.2337.
    PubMed     Text format    

  11. HILLIARD ME, Hagger V, Hendrieckx C, Anderson BJ, et al
    Strengths, Risk Factors, and Resilient Outcomes in Adolescents With Type 1 Diabetes: Results From Diabetes MILES Youth-Australia.
    Diabetes Care. 2017 Apr 26. pii: dc162688. doi: 10.2337/dc16-2688.
    PubMed     Text format     Abstract available


    Diabetes Educ

  12. MONTGOMERY J, Lu J, Ratliff S, Mezuk B, et al
    Food Insecurity and Depression Among Adults With Diabetes: Results From the National Health and Nutrition Examination Survey (NHANES).
    Diabetes Educ. 2017 Apr 1:145721717699890. doi: 10.1177/0145721717699890.
    PubMed     Text format     Abstract available

  13. MCEWEN MM, Pasvogel A, Murdaugh C, Hepworth J, et al
    Effects of a Family-based Diabetes Intervention on Behavioral and Biological Outcomes for Mexican American Adults.
    Diabetes Educ. 2017 Apr 1:145721717706031. doi: 10.1177/0145721717706031.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  14. PARK J, Park SW, Yoon KH, Kim SR, et al
    Efficacy and Safety of Evogliptin Monotherapy in Patients with Type 2 Diabetes and Moderately Elevated HbA1c by Diet and Exercise.
    Diabetes Obes Metab. 2017 Apr 27. doi: 10.1111/dom.12987.
    PubMed     Text format     Abstract available

  15. FADINI GP, Saragoni S, Russo P, Degli Esposti L, et al
    Intraclass differences in the risk of hospitalisazion for heart failure among type 2 diabetic patients initiating a dipeptydil peptidase-4 inhibitor or a sulphonylurea. Results from the OsMed Health-DB registry.
    Diabetes Obes Metab. 2017 Apr 21. doi: 10.1111/dom.12979.
    PubMed     Text format     Abstract available

  16. GANTZ I, Okamoto T, Ito Y, Okuyama K, et al
    A randomized, placebo- and sitagliptin-controlled trial of the safety and efficacy of omarigliptin, a once-weekly DPP-4 inhibitor, in Japanese patients with type 2 diabetes.
    Diabetes Obes Metab. 2017 Apr 27. doi: 10.1111/dom.12988.
    PubMed     Text format     Abstract available

  17. HANEFELD M, Arteaga JM, Leiter LA, Marchesini G, et al
    Efficacy and safety of lixisenatide in patients with type 2 diabetes and renal impairment.
    Diabetes Obes Metab. 2017 Apr 27. doi: 10.1111/dom.12986.
    PubMed     Text format     Abstract available

  18. TONNEIJCK L, Muskiet MHA, Smits MM, Hoekstra T, et al
    Postprandial renal haemodynamic effect of lixisenatide versus once-daily insulin glulisine in type 2 diabetes patients on insulin-glargine: an 8-week, randomised, open-label trial.
    Diabetes Obes Metab. 2017 Apr 27. doi: 10.1111/dom.12985.
    PubMed     Text format     Abstract available

  19. OWENS D, Bolli G, Charbonnel B, Haak T, et al
    Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/ml added to oral antidiabetes agents in type 2 diabetes.
    Diabetes Obes Metab. 2017 Apr 27. doi: 10.1111/dom.12966.
    PubMed     Text format     Abstract available

  20. DAVIES MJ, Leiter LA, Guerci B, Grunberger G, et al
    Impact of baseline HbA1c, diabetes duration and BMI on clinical outcomes in the LixiLan-O trial testing iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) versus insulin glargine and lixisenatide monocomponents.
    Diabetes Obes Metab. 2017 Apr 22. doi: 10.1111/dom.12980.
    PubMed     Text format     Abstract available

  21. CERIELLO A, De Cosmo S, Rossi MC, Lucisano G, et al
    Variability in HbA1c, blood pressure, lipid parameters and serum uric acid and risk of development of chronic kidney disease in type 2 diabetes.
    Diabetes Obes Metab. 2017 Apr 21. doi: 10.1111/dom.12976.
    PubMed     Text format     Abstract available

  22. ENGEL SS, Suryawanshi S, Stevens SR, Josse RG, et al
    Safety of Sitagliptin in Patients with Type 2 Diabetes and Chronic Kidney Disease: Outcomes from TECOS.
    Diabetes Obes Metab. 2017 Apr 22. doi: 10.1111/dom.12983.
    PubMed     Text format     Abstract available

  23. OWENS DR, Monnier L, Barnett AH
    Future challenges and therapeutic opportunities in type 2 diabetes: changing the paradigm of current therapy.
    Diabetes Obes Metab. 2017 Apr 21. doi: 10.1111/dom.12977.
    PubMed     Text format     Abstract available


    Diabetologia

  24. LECKA-CZERNIK B
    Diabetes, bone and glucose-lowering agents: basic biology.
    Diabetologia. 2017 Apr 22. doi: 10.1007/s00125-017-4269.
    PubMed     Text format     Abstract available

  25. BRUNKWALL L, Orho-Melander M
    The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities.
    Diabetologia. 2017 Apr 22. doi: 10.1007/s00125-017-4278.
    PubMed     Text format     Abstract available

  26. BLOEM SJ, Roep BO
    The elusive role of B lymphocytes and islet autoantibodies in (human) type 1 diabetes.
    Diabetologia. 2017 Apr 24. doi: 10.1007/s00125-017-4284.
    PubMed     Text format     Abstract available

  27. LITHOVIUS R, Toppila I, Harjutsalo V, Forsblom C, et al
    Data-driven metabolic subtypes predict future adverse events in individuals with type 1 diabetes.
    Diabetologia. 2017 Apr 24. doi: 10.1007/s00125-017-4273.
    PubMed     Text format     Abstract available

  28. THOMSEN SK, Gloyn AL
    Human genetics as a model for target validation: finding new therapies for diabetes.
    Diabetologia. 2017 Apr 26. doi: 10.1007/s00125-017-4270.
    PubMed     Text format     Abstract available

  29. YOON S, Cho H, Kim J, Lee DW, et al
    Brain changes in overweight/obese and normal-weight adults with type 2 diabetes mellitus.
    Diabetologia. 2017 Apr 27. doi: 10.1007/s00125-017-4266.
    PubMed     Text format     Abstract available


    Eur J Endocrinol

  30. DIAMANTI-KANDARAKIS E, Dattilo M, Macut D, Duntas L, et al
    MECHANISMS IN ENDOCRINOLOGY: Aging and anti-aging: a Combo-Endocrinology overview.
    Eur J Endocrinol. 2017;176:R283-R308.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  31. ZIEGLER D, Edmundson S, Gurieva I, Mankovsky B, et al
    Predictors of response to treatment with actovegin for 6 months in patients with type 2 diabetes and symptomatic polyneuropathy.
    J Diabetes Complications. 2017 Mar 30. pii: S1056-8727(16)30508.
    PubMed     Text format     Abstract available

  32. GAUCI R, Hunter M, Bruce DG, Davis WA, et al
    Anemia complicating type 2 diabetes: Prevalence, risk factors and prognosis.
    J Diabetes Complications. 2017 Apr 6. pii: S1056-8727(16)31103.
    PubMed     Text format     Abstract available

  33. KALYANI RR, Ji N, Carnethon M, Bertoni AG, et al
    Diabetes, depressive symptoms, and functional disability in African Americans: the Jackson Heart Study.
    J Diabetes Complications. 2017 Mar 9. pii: S1056-8727(16)30804.
    PubMed     Text format     Abstract available


    J Hypertens

  34. FUNCK KL, Laugesen E, Ovrehus K, Jensen JM, et al
    Increased high-risk coronary plaque burden is associated with arterial stiffness in patients with type 2 diabetes without clinical signs of coronary artery disease: a computed tomography angiography study.
    J Hypertens. 2017;35:1235-1243.
    PubMed     Text format     Abstract available


    JAMA

  35. WANG H, Lai Y
    Urban-Rural Differences in Diabetes in China.
    JAMA. 2017;317:1688-1689.
    PubMed     Text format    

  36. BRAGG F, Li L, Chen Z
    Urban-Rural Differences in Diabetes-Associated Mortality in China-Reply.
    JAMA. 2017;317:1689.
    PubMed     Text format    

  37. SLOMSKI A
    Bariatric Surgery Has Durable Effects in Controlling Diabetes.
    JAMA. 2017;317:1615.
    PubMed     Text format    


    Lancet Diabetes Endocrinol


  38. Correction to Lancet Diabetes Endocrinol 2017: 5: 174-83.
    Lancet Diabetes Endocrinol. 2017;5:e3.
    PubMed     Text format    


  39. Correction to Lancet Diabetes Endocrinol 2017; 5: 240-41.
    Lancet Diabetes Endocrinol. 2017;5:e3.
    PubMed     Text format    


  40. Correction to Lancet Diabetes Endocrinol 2017: 5: 125-33.
    Lancet Diabetes Endocrinol. 2017;5:e3.
    PubMed     Text format    

  41. BARNETT AH, O'Hare P, Halcox J
    Guidelines for type 2 diabetes: keeping a finger on the pulse.
    Lancet Diabetes Endocrinol. 2017 Apr 19. pii: S2213-8587(17)30136.
    PubMed     Text format    


    Med Care

  42. SHRESTHA SS, Zhang P, Thompson TJ, Gregg EW, et al
    Medical Expenditures Associated With Diabetes Among Youth With Medicaid Coverage.
    Med Care. 2017 Apr 21. doi: 10.1097/MLR.0000000000000725.
    PubMed     Text format     Abstract available


    N Engl J Med

  43. LAVERY K, Gilden DJ, Saint S, Judson MA, et al
    A Bare-Bones Approach.
    N Engl J Med. 2017;376:1371-1376.
    PubMed     Text format    


    Pediatr Diabetes

  44. FAZELI FARSANI S, Abdullah-Koolmees H, Souverein PC, de Boer A, et al
    Psychiatric medication use before and after the onset of type 1 diabetes in children and adolescents: A population-based cohort study.
    Pediatr Diabetes. 2017 Apr 24. doi: 10.1111/pedi.12529.
    PubMed     Text format     Abstract available

  45. MALACHOWSKA B, Borowiec M, Antosik K, Michalak A, et al
    Monogenic diabetes prevalence among Polish children-Summary of 11 years-long nationwide genetic screening program.
    Pediatr Diabetes. 2017 Apr 24. doi: 10.1111/pedi.12532.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  46. ALBERS DJ, Levine M, Gluckman B, Ginsberg H, et al
    Personalized glucose forecasting for type 2 diabetes using data assimilation.
    PLoS Comput Biol. 2017;13:e1005232.
    PubMed     Text format     Abstract available


    PLoS One

  47. P S, D TK, C GPD, R S, et al
    Determining the role of missense mutations in the POU domain of HNF1A that reduce the DNA-binding affinity: A computational approach.
    PLoS One. 2017;12:e0174953.
    PubMed     Text format     Abstract available

  48. GOMEZ-SANCHEZ L, Garcia-Ortiz L, Patino-Alonso MC, Recio-Rodriguez JI, et al
    Glycemic markers and relation with arterial stiffness in Caucasian subjects of the MARK study.
    PLoS One. 2017;12:e0175982.
    PubMed     Text format     Abstract available

  49. SHEPHERD JA, Ng BK, Fan B, Schwartz AV, et al
    Modeling the shape and composition of the human body using dual energy X-ray absorptiometry images.
    PLoS One. 2017;12:e0175857.
    PubMed     Text format     Abstract available

  50. FUNAKOSHI M, Azami Y, Matsumoto H, Ikota A, et al
    Socioeconomic status and type 2 diabetes complications among young adult patients in Japan.
    PLoS One. 2017;12:e0176087.
    PubMed     Text format     Abstract available

  51. MICHA R, Shulkin ML, Penalvo JL, Khatibzadeh S, et al
    Etiologic effects and optimal intakes of foods and nutrients for risk of cardiovascular diseases and diabetes: Systematic reviews and meta-analyses from the Nutrition and Chronic Diseases Expert Group (NutriCoDE).
    PLoS One. 2017;12:e0175149.
    PubMed     Text format     Abstract available

  52. WESTERGREN HU, Michaelsson E, Blomster JI, Miliotis T, et al
    Determinants of coronary flow reserve in non-diabetic patients with chest pain without myocardial perfusion defects.
    PLoS One. 2017;12:e0176511.
    PubMed     Text format     Abstract available

  53. VIAZZI F, Piscitelli P, Giorda C, Ceriello A, et al
    Metabolic syndrome, serum uric acid and renal risk in patients with T2D.
    PLoS One. 2017;12:e0176058.
    PubMed     Text format     Abstract available


    Transplant Proc

  54. KIM K, Jeong DW, Lee YH, Kim YG, et al
    Everolimus-Induced Systemic Serositis After Simultaneous Liver and Kidney Transplantation: A Case Report.
    Transplant Proc. 2017;49:181-184.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: